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Abstract  
The spatial regulation of combinatorial expression of Hox genes is critical for 
determining hindbrain rhombomere (r) identities. To address the cross-regulatory 
relationship between Hox genes in hindbrain neuronal specification, we have generated a 
gain-of-function transgenic mouse mutant Hoxb3
Tg
 using the Hoxb2 r4-specific enhancer 
element. Interestingly, in r4 of the Hoxb3
Tg 
mutant where Hoxb3 was ectopically 
expressed, the expression of Hoxb1 was specifically abolished. The hindbrain neuronal 
defects of the Hoxb3
Tg 
mutant mice were similar to those of Hoxb1
-/- 
mutants. Therefore, 
we hypothesized that Hoxb3 could directly suppress Hoxb1 expression. We first 
identified a novel Hoxb3 binding site S3 on the Hoxb1 locus and confirmed protein 
binding to this site by EMSA, and by in vivo ChIP analysis using P19 cells and hindbrain 
tissues from the Hoxb3
Tg 
mutant. We further showed that Hoxb3 could suppress Hoxb1 
transcriptional activity by chick in ovo luciferase reporter assay. Moreover, in E10.5 
wildtype caudal hindbrain, where Hoxb1 is not expressed, we showed by in vivo ChIP 
that Hoxb3 was consistently bound to the S3 site on the Hoxb1 gene. This study reveals a 
novel negative regulatory mechanism by which Hoxb3 as a posterior gene serves to 
restrict Hoxb1 expression in r4 by direct transcriptional repression to maintain the 
rhombomere identity.  
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Introduction 
The mammalian hindbrain functions to control motor activity, sensory perception, 
balance and coordination. The complex neuronal circuits that connect neurons to their 
targets depend on the generation of distinct neuronal populations in a precise spatial order 
along the anteroposterior and dorsoventral axes in the developing hindbrain. During 
embryogenesis, the hindbrain undergoes transient segmentation into seven rhombomeres. 
Each rhombomere has a unique identity that defines the generation of specific types of 
branchial, somatic and visceral motor neurons. The combinatorial expression pattern of 
Hox genes forms the branchial ‘Hox code’ that confers the axial identity of the hindbrain 
rhombomeres, specifies the generation of appropriate sensory and motor neurons and 
coordinates the innervation of tissues in the branchial region (Briscoe and Wilkinson, 
2004; Fraser et al., 1990; Keynes and Krumlauf, 1994; Kulesa and Fraser, 1998; Kulesa 
and Fraser, 2000; Lumsden and Krumlauf, 1996).  
 
A characteristic feature of mammalian Hox genes is the temporal and spatial colinear 
relationship between their organization within gene clusters and their ordered overlapping 
expression patterns along the anterior-posterior axis during development. The 
spatiotemporal expression patterns of Hox genes in the hindbrain are subjected to a 
complex network of transcriptional and post-transcriptional regulations. There are also 
auto- and cross-regulations among Hox genes that contribute to the establishment and 
maintenance of their dynamic expression patterns during hindbrain development 
(Maconochie et al., 1996; Tumpel et al., 2009). By genetic mutation studies in mice, a 
number of Hox genes have been demonstrated to function as positive regulators to control 
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Hox expression. The negative cross-regulatory mechanism that is essential for restricting 
the expression and function of Hox genes to specific anteroposterior domains, which 
leads to the posterior prevalence of HOM-C genes in Drosophila (Duboule and Morata, 
1994; Morata, 1993), is not well described among mammalian Hox genes.  
 
In the developing mouse neural tube, the earlier expressing genes are initiated from 
posterior and their expression domains extend to anterior. Later, their anterior expression 
boundaries are established and coincide with the hindbrain rhombomere boundaries. The 
posterior boundaries of expression of Hox genes in the neural tube are not well defined, 
with the exception of Hoxb1 which is initially expressed broadly in the neural tube, but 
restricted to r4 by E9.0. The initiation of Hoxb1 expression is achieved by retinoid 
signaling (Huang et al., 2002; Marshall et al., 1994), positive auto-regulation by Hoxb1 
further maintains its expression in r4 (Ferretti et al., 2005; Gavalas et al., 2003; Popperl et 
al., 1995; Studer et al., 1998). Retinoic acid can also act as a negative regulator to repress 
Hoxb1 expression in r3/r5 from E9.5 and at later stages (Studer et al., 1994). Nevertheless, 
these negative regulatory mechanisms have been shown to be insufficient in restricting 
the expression of Hoxb1 to r4. In a transgenic experiment in defining the genomic 
sequence requirement, additional negative regulatory mechanisms have been implicated 
in the repression of Hoxb1 expression (Fox, 2000). Therefore, how Hoxb1 expression is 
restricted specifically within the r4 boundary is still not fully understood. The Hoxb3 
gene is expressed in the posterior neural tube and extended to r5, with an anterior 
boundary at r4/5 and this expression domain is complementary to the expression territory 
of Hoxb1. Based on the evolutionary conserved posterior prevalence model, Hoxb3 could 
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be a candidate negative regulator of Hoxb1 and suppress the expression of Hoxb1 in the 
neural tube caudal to r4. However, the molecular mechanism for the posterior gene 
Hoxb3 to repress the anterior gene Hoxb1 is unknown. 
 
By genetic analysis using gain- or loss-of-function mutations and examining neuronal 
abnormalities of mutant embryos, it has been shown that Hox genes are required in early 
rhombomere patterning and subsequent specification of neuronal cell fates. In particular, 
the Hox1 and Hox3 genes are required for normal rhombomere (r) 4 and r5 neuronal 
specification. Targeted inactivation of Hoxa1 leads to reduction of r4 and absence of r5, 
loss of r5 lateral motor nuclei that send efferent fibers to the VII
th
 nerve, and altered 
expression of Math3, Phox2b, Gata2 in r4 with many associated neuronal defects 
(Carpenter et al., 1993; Gavalas et al., 2003). Disruption of Hoxb1 leads to a failure to 
specify facial brachiomotor neurons (FBM) and contralateral vestibuloacoustic (CVA) 
efferent neurons within r4, and migration of FBMs to r5 and r6 is also defective (Goddard 
et al., 1996; Studer et al., 1996). The phenotype of Hoxb2 knockout mutants is similar to 
those of Hoxb1 knockout mutants but less severe (Gavalas et al., 2003); Hoxb2 
inactivation leads to reduced Math3, Gata2 and Phox2b expression in r4, and reduced 
migration of r4 FBMs to r5. While individual Hox3 mutants did not have evident 
hindbrain defects, in Hoxa3 and Hoxb3 double knockout mutants, the somatic 
motoneurons (SMNs) in r5 are completely absent at E11.5, Olig2 expression which 
marks SMN progenitors are absent and the region normally occupied by SMNs are 
instead occupied by V2 neurons (Gaufo et al., 2003). Over-expression of Hoxa3 in chick 
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anterior hindbrain could also lead to generation of ectopic SMNs, suggesting that Hoxa3 
can specify somatic motor neuron cell fate (Guidato et al., 2003).   
 
In order to address the cross-regulatory relationship between Hoxb1 and Hoxb3, and to 
investigate the effect of altering the combinatorial Hox code on hindbrain patterning and 
neuronal specification, we have generated a gain-of-function Hoxb3
Tg
 transgenic mutant 
using the Hoxb2 r4-specific enhancer element (Ferretti et al., 2000; Maconochie et al., 
1997) to ectopically express Hoxb3 in r4. Interestingly, we found that the Hoxb3
Tg 
mutant 
mice displayed a loss of Hoxb1 expression in r4, and the hindbrain neurogenesis defects 
were similar to the Hoxb1
-/- 
mutant phenotypes (Gaufo et al., 2000; Gavalas et al., 2003; 
Goddard et al., 1996; Studer et al., 1996). To further investigate whether Hoxb3 could 
directly repress Hoxb1 expression, we have identified a novel Hoxb3 binding site on the 
Hoxb1 locus by bioinformatics analysis. Moreover, by in vitro and in vivo molecular 
analysis we have obtained molecular evidence that Hoxb3 directly binds to Hoxb1 
through the Hoxb3 binding site and negatively regulate Hoxb1 transcription. Here we 
demonstrate a novel negative regulatory mechanism by which Hoxb3 as a posterior gene 
serves to restrict Hoxb1 expression in r4 by direct transcriptional repression to maintain 
the rhombomere identity in order to specify distinct neuronal subtypes. 
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Materials and Methods 
 
Generation of Hoxb3 gain-of-function transgenic mutants 
The transgenic construct was generated by cloning the 1.4 kb Hoxb2 r4 and 2
nd
 BA 
specific enhancer element (Ferretti et al., 2000; Maconochie et al., 1997; Manzanares et 
al., 1999), β-globin promoter fragment, 2.6 kb Hoxb3 genomic DNA and SV40 3’ 
untranslated and polyadenylation region into the pPolyIII vector. For the Hoxb3 genomic 
DNA,  the 5’ fragment of ~200 bp from the ATG start codon to the SacI site was 
amplified by PCR using the primer pairs 5’-TCTAG AGCAT GCAGA AAGCC 
ACCTA-3’ and 5’-TGCAG CTGCC ATTGA GCTCC-3’. The 3’ fragment was a 2.4 kb 
SacI-HindIII genomic DNA of Hoxb3 containing a myc-tag at the BamHI site (Sham et 
al., 1992). The DNA transgene was released from the vector by XhoI digestion and the 
5.4 kb transgenic fragment was isolated and purified for oocyte microinjection. For the 
generation of transgenic founders, fertilized oocytes from superovulated FVB mice were 
used. Three independent transgenic mouse lines, designated Hoxb3
Tg2
, Hoxb3
Tg7
 and 
Hoxb3
Tg8
, were maintained in FVB genetic background. 
 
Mouse genotyping 
For genotyping of Hoxb3 mutants by PCR amplification, the primers used were 
5’-CCACT AGGCC TAGAC TAGC-3’ derived from the Hoxb2 r4 enhancer and 
5’-TGCAG CTGCC ATTGA GCTCC-3’ derived from exon 3 of Hoxb3 (arrows in Fig. 
1A). Genomic DNA was digested with SacI, the BglII-EcoRI fragment from the Hoxb2 
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r4 enhancer and BamHI-HindIII fragment from the Hoxb3 gene were used as 5’ and 3’ 
probes in Southern hybridization. 
 
RNA in situ hybridization 
Whole-mount in situ hybridization was performed using DIG-labeled riboprobes and 
visualized by NBT/BCIP (Roche) (Wilkinson et al., 1992). 
 
Neuronal tract tracing 
Facial branchial motoneurons (FBMs) and contralateral vestibuloacoustic (CVA) neurons 
of E11.5 mouse embryos were labeled using NeuroVue
® 
dye-coated filters (MTTI)  
(Fritzsch and Nichols, 1993). Selective tracing was achieved by inserting the red dye 
filter into the inner ear for efferent neurons and inserting the green dye filter into the 
facial nerve for facial branchial and visceral motoneurons. Labeled brain samples were 
dissected and flat-mounted in glycerol. Fluorescent images were obtained using a Leica 
LAS AF confocal microscope. 
 
Bioinformatics analysis of Hoxb3 binding site  
Hoxb3 consensus binding site TCATTAATTGGC (core binding sequence underlined) 
was defined by comparative genomic analysis (Sham et al, unpublished). To identify 
potential Hoxb3 binding sites in the Hoxb1 locus, the conserved regions among the 
Hoxb1 and flanking sequences from six vertebrate species were found in UCSC Genome 
database. 
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Electrophoretic Mobility Shift Assay (EMSA) 
Oligonucleotides, S3-WT, 5’-TCACT GCTTT TCTTC ATTTA ATTGA AATTG 
CCATC AAGCT TGG-3’; S3-M1, 5’-TCACT GCTTT TCCCG GCCTA ATTGA 
AATTG CCATC AAGCT TGG-3’; S3-M2, 5’-TCACT GCTTT TCTTC ATCCG 
GCCCA AATTG CCATC AAGCT TGG-3’; S3-M12, 5’-TCACT GCTTT TCCCG 
GCCCC GGCCA AATTG CCATC AAGCT TGG-3’, designed with 5’-overhangs after 
annealing with their complementary strands, were labeled with [ -
32
P]dCTP (PB10205; 
Amersham) by end-filling 5’-overhangs using Klenow fragment. GST-Hoxb3 fusion 
protein and DNA-protein binding reactions were set up as previously described (Yau et 
al., 2002). A 20 l binding reaction contained 40,000 cpm oligonucleotide probe, 500 ng 
poly(dIdC-dIdC), protein (GST-Hoxb3, 0.2–1.6 g), 20 mM Hepes–KOH (pH 7.9), 100 
mM KCl, 0.25 g/ l BSA, 2 mM DTT, 1 mM EDTA, 12% glycerol. The binding 
reaction was incubated at 24°C for 30 min. The samples were separated in a 4% 
acrylamide glycerol gel. 
 
P19 Cell Culture 
P19 cells were cultured on gelatin-coated (0.1%) tissue culture dishes in DMEM medium 
(Gibco) supplemented with 10% FBS. On day 0, cells were detached and cultured in 
bacterial culture dish at a density of 5x10
4 
cells/ml with DMEM medium supplemented 
with 10% FBS. On day 1, 10
-8
M RA was added to the medium. The medium was 
refreshed with the same concentration of RA on day 3, and the P19 cells were harvested 
for ChIP assay on day 4.  
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Chromatin immunoprecipitation (ChIP) assay 
ChIP assay (Hu and Rosenblum, 2005) was performed with the following modifications. 
For RA-treated P19 cells, 1x10
6
 cells were harvested for each assay. For in vivo ChIP, the 
forebrain, spinal cord and the ectopic sites r4/2
nd
 BA of 4 litters of E9.5 wildtype or 
mutant embryos were dissected in PBS. The cells or fresh tissues were fixed in 1% 
formaldehyde for 20 minutes at 25°C, and then disintegrated with RIPA buffer. The 
cross-linked material was sonicated to 200-1000 bp fragments (Vibracell sonicator; seven 
times for 10 seconds at 40% output), 2-4 µg of Hoxb1 (Santa Cruz, H170, sc-28603) or 
Hoxb3 antibody (Santa Cruz, C20, sc-17169) or normal rabbit IgG were then used to pull 
down the chromatin. PCR amplifications were performed using the following primers: for 
S1: forward: 5’-ACGTA GGTGG TGACT TGGAA CT-3’, reverse: 5’-AGAGA TGGCC 
TATGT GCTGT GA-3’; for S3: forward: 5’-TGGGG TGCAG CGATG AGGAA-3’, 
reverse: 5’-GCCCT AACCA CTGTC CCGCC CT-3’; for B3ARE: forward: 5’-TGGAA 
ACTGG TAGGT GTGTG GGC-3’, reverse: 5’-TGTAT GAAGG TGAAG GAGCA 
GA-3’; for B1ARE: forward: 5’-TCCCT CTGGT CCCTT CTTTC-3’, reverse: 
5’-GAGCT GAGCA GGGGG GAAAA-3’.  
 
Chick in ovo electroporation and luciferase activity assay 
pCIG-Hoxb3 cDNA construct or pCIG empty expression vector as control was 
electroporated into the hindbrain r3-5 regions of Hamburger and Hamilton (HH) stage 11 
to 12 chick embryos along with a firefly luciferase reporter construct containing a 600 bp 
fragment including the Hoxb3 binding site S3 and the RARE 3’DR2 element of the 
Hoxb1 loci (Hoxb1-luc), or with the mutation of Hoxb3-binding site S3 (mHoxb1-luc 
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constructs), or pGL3 luciferase vector as control, and the CMV-Renilla luciferase 
plasmid for normalization (Promega). After 24 hours, embryos were processed for the 
luciferase assay as previously described (Dessaud et al., 2007). Briefly, embryos were 
homogenized in passive lysis buffer on ice and firefly and Renilla luciferase activities 
were measured with the Dual Luciferase Reporter Assay System (Promega).     
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Results 
 
Hoxb3 is ectopically expressed in r4 of Hoxb3
Tg
 transgenic mutant 
Using the transgenic construct with Hoxb2 r4-specific enhancer and Hoxb3 coding 
sequence (Fig.1A), 8 transgenic founders (designated Hoxb3
Tg1
 to Hoxb3
Tg8
) were 
generated. Among the 8 founders, only Hoxb3
Tg2
, Hoxb3
Tg7
 and Hoxb3
Tg8
 were fertile and 
3 independent transgenic mouse lines were subsequently established. The Hoxb3
Tg
 
mutants were genotyped by PCR (Fig. 1A); by Southern blotting analysis, the Hoxb3
Tg2
, 
Hoxb3
Tg7
 and Hoxb3
Tg8
 transgenic mutant lines were estimated to contain approximately 
12, 2 and 6 copies of transgenic DNA respectively (Fig. 1B). By Western blotting, ectopic 
Hoxb3 protein could be detected in rhombomere 4 and the second branchial arch in E10.5 
Hoxb3
Tg
 mutant embryos obtained from the three different mouse lines (Fig. 1C). 
Wildtype, heterozygous (Hoxb3
Tg/+
)
 
and homozygous (Hoxb3
Tg/Tg
) mice were born in 
expected Mendelian ratio. All three Hoxb3
Tg2
, Hoxb3
Tg7
 and Hoxb3
Tg8
 transgenic mouse 
lines displayed similar phenotypes of craniofacial dysmorphology (Suppl. Fig. 1 and 
Table 1). Hoxb3
Tg/+ 
mutants appeared smaller in size (data not shown) and Hoxb3
Tg/Tg
 
mutants died shortly after birth, possibly due to feeding disability rather than a direct 
effect of the transgene. We focused our analysis on the Hoxb3
Tg2
 line which has the 
highest number of copies of the transgene.  
 
In Hoxb3
Tg/+ 
embryos, ectopic Hoxb3 expression could be detected in the anterior neural 
tube as early as E7.5 and E8.5 (Fig. 3E, F). At E9.0, ectopic Hoxb3 was expressed in r4 
of the neural tube, the entire developing otic cup, 1
st 
and 2
nd
 BAs (Fig. 1D). At E9.5, 
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ectopic expression of Hoxb3 was maintained in the hindbrain at r4 (Fig. 3G), 2
nd
 BA, the 
proximal surface ectoderm of the 1
st
 BA and dorsal region of the otic vesicle (Fig. 1D). 
Interestingly, endogenous expression of Hoxb3 in r5 was also maintained at a high level 
in the mutant when compared with wildtype at E10.5 (Fig. 1D and Fig. 3H). The 
posterior expression of Hoxb3 in the neural tube was not affected in Hoxb3
Tg/+ 
embryos.  
 
Hoxb3
Tg/+
 mutants have facial nerve abnormalities 
Compared to wildtype (Fig. 2A-C and Suppl. Fig. 1A,B), 6 out of 8 transgenic founder 
mice showed similar overt phenotypes including narrower face (Fig. 2E and Suppl. Fig. 
1D,G,J); receded lower lip, impaired whisker movement and facial paralysis (Fig. 2F and 
Suppl. Fig. 1E,H,K); abnormal preyer reflex, abnormal reaching response (Fig. 2G), head 
tilting and circling behaviour (data not shown). Wildtype and Hoxb3
Tg2/+
 mutant adults 
were sacrificed and facial somatic motor components of the VIIth cranial nerve were 
exposed for analysis. In wildtype (Fig. 2D and Suppl. Fig. 1C), the zygomatic, buccal and 
the mandibular branches of the facial nerve were readily recognizable. However, in 
mutant adults from Hoxb3
Tg2/+
 (Fig. 2H) and other transgenic lines (Suppl. Fig. 1F,I,L), 
the mandibular branch of the facial nerve was either reduced or absent which resembled 
that of the Hoxb1 knockout mice reported previously (Goddard et al., 1996; Rossel and 
Capecchi, 1999; Studer et al., 1998; Studer et al., 1996).  
 
Hindbrain segmentation in Hoxb3
Tg/+
 mutants 
As Hoxb3 was ectopically expressed in the hindbrain at more anterior regions, and 
specifically in r4 from E9.0 onwards, we examined whether there were hindbrain 
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segmentation defects in Hoxb3
Tg
 mutants using several rhombomere-specific markers. At 
E8.5, Wnt8a was expressed in r4 of wildtype embryos (4-7 somite stage) (Fig. 3S) 
(Bouillet et al., 1996). Interestingly, in Hoxb3
Tg/+
 embryos of similar somite stages, 
expression of Wnt8a could not be detected in the mutant r4 (Fig. 3U), suggesting that the 
identity of r4 was lost in the Hoxb3
Tg
 mutant. Expression of the r3 and r5 marker genes 
Krox20 (Fig. 3Y) and EphA4 (Fig.3Z) in Hoxb3
Tg/+
 mutants at E8.5 and E9.5 were the 
same as in wildtype littermates (Fig. 3W,X). Kr expression in r5 and r6 in Hoxb3
Tg/+
 
mutants (Fig. 3V) examined at E9.5 was also the same as in wildtype (Fig. 3T). The Wnt 
8a, Krox20, EphA4 and Kr expression profiles in Hoxb3
Tg/+
 mutants indicate that 
enforced expression of Hoxb3 in r4 did not affect the establishment of the r4 territory nor 
hindbrain segmentation, but changed the identity and properties of r4.  
 
Hoxb1 is down-regulated by ectopic Hoxb3 expression in r4 
In wildtype embryos (Fig. 3I), Hoxb1 expression was activated at E7.5, and subsequently 
restricted to r4 and the posterior mesoderm at E8.5-10.5 (Fig. 3J-L). In Hoxb3
Tg/+
 
embryos (Fig. 3N), Hoxb1 expression was found to reach the anterior boundary at E7.5 as 
in wildtype embryos. Interestingly, no expression of Hoxb1 could be detected in the 
hindbrain region at E8.5 (Fig. 3O), E9.5 (Fig. 3P) or E10.5 (Fig. 3Q), though expression 
in the pre-somitic mesoderm could still be readily observed. Therefore, Hoxb1 expression 
in Hoxb3
Tg/+
 transgenic embryos was specifically abolished in r4 (Fig. 3O-Q) but was 
maintained in the posterior (Fig. 3O). Enforced expression of Hoxb3 in the anterior 
neural domains at E8.5 (arrowhead in Fig. 3F) suppressed the expression of Hoxb1 
specifically in r4, and this suppression was maintained through later stages of 
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development (Fig. 3O-Q). The suppression of Hoxb1 expression in r4 was observed in all 
three mutants lines Hoxb3
Tg2
, Hoxb3
Tg7
 and Hoxb3
Tg8
 (Suppl. Fig. 1M). Consistent with 
the suppression of Hoxb1, the expression of Hoxb2 which is a downstream target of 
Hoxb1, was specifically down-regulated in r4 where ectopic Hoxb3 was expressed in the 
Hoxb3
Tg/+
 embryos (asterisk in Fig. 3R and Suppl. Fig. 2C,D). The expression of Hoxa2 
was not affected (Suppl. Fig. 2G,H).  
 
Abnormal neurogenesis in r4 of Hoxb3
Tg/+
 mutants  
We next addressed the impact of an altered Hox code on the identity of r4 by examining 
the characteristic neurogenesis patterns in the hindbrain of the Hoxb3
Tg/+
 mutants. In 
E11.5 wildtype embryos, facial branchial motoneurons (FBMs) expressing Islet1, Phox2b 
and Tbx20 were generated in the ventral domain of r4 and started to migrate through r5 to 
r6 (Fig. 4A-C), However, in Hoxb3
Tg/+
 mutant embryos, the distinctive expression 
patterns of Islet1, Phox2b and Tbx20 in the ventral hindbrain at r4, r5 and r6 could no 
longer be observed (Fig. 4F-H). In wildtype hindbrain, Gata3 was expressed in the 
ventral region of r4 at E11.5 which is the downstream effector of Hoxb1 (Pata et al., 1999) 
(Fig. 4D), but in r4 of Hoxb3
Tg/+
 embryos the expression of Gata3 was specifically 
down-regulated (Fig. 4I). Consistent with the changes in gene expression patterns, we 
confirmed by retrograde dye-tracing experiments that the facial brachial motor nucleus 
was absent in r6 and no migration of FBMs through r5-6 could be detected (Fig. 4M), and 
the number of contralateral vestibuloacoustic (CVA) neurons migrating across the 
midline was significantly reduced (Fig. 4N) in r4 of E11.5 Hoxb3
Tg/+
 mutants. From these 
analyses, the identity of r4 was clearly lost in the Hoxb3
Tg/+
 mutant. As a consequence of 
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loss of Hoxb1 expression in r4, FBMs were not specified and the migration of motor 
neurons and CVA neurons impaired. 
 
To investigate whether the abnormal r4 phenotype in the Hoxb3
Tg/+
 mutant is due to 
loss-of-function of Hoxb1 alone, or also due to gain-of-function of Hoxb3 which might  
impose an r5-like identity, we compared the neurogenesis pattern of r4 with that of r2, r5 
and r6 in wildtype and Hoxb3
Tg/+
 mutants at E11.5. Firstly, in wildtype E11.5 embryos, 
Islet1-positive trigeminal motor nucleus had migrated from ventral to the dorsal region of 
r2 (Fig. 4O) and Islet1-positive
 
FBMs were found in ventral r4-r6 (Fig. 4O). However, in 
r4 of Hoxb3
Tg/+ 
mutants, the cluster of FBMs could not be detected, but a few 
Islet1-positive
 
motor neurons were scattered from the ventral to the dorsal region 
(asterisk in Fig. 4P). The distribution of Islet1-positive
 
motor neurons in r4 was similar to 
that in r2 of both wildtype and Hoxb3
Tg/+
 mutant embryos (Fig. 4O,P). Secondly, we 
found that Gata2, which normally marks serotonergic neurons and is absent in r4 (Fig. 
4E), was ectopically expressed in r4 in Hoxb3
Tg/+
 mutants (Fig. 4J). By immunostaining 
of hindbrain sections, we showed that 5HT-positive
 
serotonergic neurons were present in 
r2 and r5, but not in r4 of wildtype E11.5 embryos (Fig. 4Q). However, ectopic 
5HT-positive
 
serotonergic neurons were clearly present next to the floor plate in r4 of 
Hoxb3
Tg/+
 mutant embryos (Fig. 4R). Thirdly, we examined the distribution of 
Lim3-positive interneurons in ventral r4 (Fig. 4S) and found that the location of 
Lim3-positive V2 interneurons were shifted to more ventral region in r4 of Hoxb3
Tg/+
 
mutants (Fig. 4T). The depletion of islet1-positive neurons, presence of ectopic 
5HT-positive
 
serotonergic neurons, and the ventral shift of p2 and p3 progenitor domains 
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(summarized in Fig. 4) in r4 of the Hoxb3
Tg/+
 mutants are similar to the reported 
phenotype of Hoxb1
-/-
 mutant mice (Gaufo et al., 2000; Gavalas et al., 2003; Goddard et 
al., 1996; Jacob et al., 2007; Pattyn et al., 2003; Studer et al., 1996). 
 
We further examined the expression of Islet2 which marks somatic motor neurons and 
found that no ectopic Islet2 expression could be detected in r4 of Hoxb3
Tg/+ 
mutants (data 
not shown). Therefore, ectopic Hoxb3 expression in r4 was insufficient to induce somatic 
motor neuron differentiation, the characteristic neuronal subtype for r5 could not be 
found in the ectopic site of the mutant. Hence the identity of r4 was changed to an r2-like 
rhombomere but not r5. As the neurogenesis pattern of r4 in the Hoxb3
Tg/+ 
mutant is 
highly similar to that of Hoxb1
-/-
 mutant (Studer et al., 1998), the change of r4 identity in 
Hoxb3
Tg/+
 mutants is likely caused by the absence of Hoxb1 but not the presence of 
ectopic Hoxb3. Taken together, the Hoxb3
Tg/+ 
mutant is a phenocopy of the Hoxb1
-/-
 null 
mutant. 
 
Hoxb3 negatively regulates Hoxb1 by direct binding to specific genomic site 
Since expression of Hox genes are subjected to cross-regulation, we explored the 
possibility that Hoxb3 may regulate Hoxb1 expression directly by specific binding to 
cis-acting sequence elements. We have previously defined a Hoxb3 consensus binding 
site TCATTAATTGGC by comparative genomic analysis (Sham et al. unpublished). To 
identify potential Hoxb3 binding sites in the Hoxb1 locus, we searched within the Hoxb1 
genomic sequences from conserved regions among six vertebrate species. Within the 
conserved regions, three potential Hoxb3 binding sties, S1, S2 and S3, with sequence 
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similarity to the Hoxb3 consensus binding site could be identified (Fig. 5A,B). The S1 
and S3 sites are located in the 5’ and 3’ flanking regions of Hoxb1 respectively, both of 
them have a TAAT core motif found in the consensus binding sequence of Hoxb3. The 
S2 site is located 170 bp downstream of the Hoxb1 auto-regulatory element B1ARE and 
has two adjacent core motifs. 
 
As the S3 site located 2.5 kb 3’ to the Hoxb1 coding region has an identical core 
sequence to our predicted Hoxb3 consensus binding site, we first tested the binding of 
Hoxb3 to the S3 site by in vitro electrophoretic mobility shift assay using bacterial 
expressed GST-Hoxb3 fusion protein (Yau et al., 2002). We demonstrated that 
GST-Hoxb3 fusion protein could bind to oligonucleotides containing the S3 site, the 
amount of bound oligonucleotides was proportional to the amount of GST-Hoxb3 fusion 
protein used (Fig. 5C, lanes 2-4). The binding of GST-Hoxb3 to the S3 site could be 
competed out with unlabelled wildtype S3 oligonucleotides (Fig. 5C, lanes 5-7), but not 
with unlabelled oligonucleotides containing mutated S3 binding sites M1, M2 and M12 
(Fig. 5C, lanes 8-10). Therefore, GST-Hoxb3 fusion protein could bind specifically to the 
S3 site on Hoxb1. Similar EMSA were performed using oligonucleotides containing the 
S1 or S2 sites but we could not detect any specific binding of Hoxb3 to these sites (data 
not shown).  
 
To test that Hoxb3 can specifically bind to the S3 binding site on Hoxb1, in vivo ChIP 
assays were performed using P19 teratocarcinoma cells and mouse embryos. Several test 
and control sets of primers were used to amplify chromatin fragments 
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immunoprecipitated with Hox antibodies in the ChIP assays, namely S1; S2/B1ARE 
which contains the closely linked S2 site and Hoxb1 auto-regulatory element; S3; and 
B3ARE which contains the Hoxb3 auto-regulatory element (Yau et al., 2002). P19 cells 
were treated with retinoic acid (RA) to mimic the hindbrain microenvironment (Okada et 
al., 2004). Our ChIP results showed that Hoxb3 antibody could precipitate the 
Hoxb3-B3ARE complex as expected, it also specifically pulled down the Hoxb3-S3 
complex, but no binding to the S1 or S2/B1ARE sites could be detected (Fig. 6A). The 
pull-down of the Hoxb3-S3 chromatin complex was highly specific, as no complex 
formation could be detected when Hoxb4 or Hoxb1 antibodies, or IgG were used as 
controls in the ChIP assay. We showed that Hoxb1 antibody could pull down the 
S2/B1ARE complex, which was due to the presence of the closely linked Hoxb1 
auto-regulatory site. Therefore, we have clearly demonstrated that in RA-treated P19 
cells which expressed Hoxb genes endogenously, Hoxb3 protein could specifically bind 
to the S3 site on the Hoxb1 gene. 
 
To confirm that Hoxb3 could bind directly to Hoxb1 during mouse embryogenesis, we 
isolated forebrain, caudal hindbrain/spinal cord and the ectopic sites r4/2
nd
 BA tissue 
extracts from E9.5 wildtype and Hoxb3
Tg/+ 
mutant embryos and performed ChIP assays 
as above (Fig. 6B). In wildtype embryos, Hoxb3 protein could bind to the S3 site on 
Hoxb1 and the B3ARE site on Hoxb3 in the caudal hindbrain/spinal cord, indicating that 
Hoxb3 could directly regulate Hoxb1, and activate Hoxb3 through auto-regulation in this 
region. No binding could be detected in the forebrain or r4/2
nd
 BA tissues.  In the 
Hoxb3
Tg/+
 mutant (Fig. 6B), Hoxb3 could bind to the S3 site in the caudal 
 20 
hindbrain/spinal cord as well as r4/2
nd
 BA, indicating that Hoxb3 could directly mediate 
the down-regulation of Hoxb1 via binding to the S3 site. Interestingly, in the mutant 
embryos, Hoxb3 could bind to the B3ARE not only in the caudal hindbrain/spinal cord 
region, but also in the r4/2
nd
 BA region, suggesting that there could be Hoxb3 
auto-regulation in the ectopic site which sustained the expression of Hoxb3 in r4 of the 
transgenic mutant embryos.  No binding could be detected in Hoxb3
-/-
 mutant embryo 
samples (Manley and Capecchi, 1997), further confirming the specificity of the Hoxb3 
antibody used. In summary, by in vitro EMSA and in vivo ChIP analyses, we have 
provided strong evidence that Hoxb3 could bind directly to the Hoxb1 gene. Hoxb3 
protein was bound to the S3 site on Hoxb1 in r4 of the Hoxb3
Tg/+ 
mutant embryos, and in 
the caudal hindbrain/spinal cord of both wildtype and mutant embryos. 
 
To assess whether Hoxb3 could negatively regulate Hoxb1 transcription through the S3 
Hoxb3 binding site in vivo, we examined the effects of overexpression of Hoxb3 in the 
chick hindbrain on Hoxb1 luciferase reporter constructs by in ovo electroporation 
experiments (Fig. 6C). Using a wildtype Hoxb1 reporter (Hoxb1-luc), luciferase activity 
could be detected (Fig. 6C, bar 1); but in the presence of Hoxb3, the transcriptional 
activity of this Hoxb1 reporter was significantly reduced (p=0.026) (Fig. 6C, bar 2). In 
contrast, Hoxb3 expression could not inhibit the transcriptional activity of the mutant 
Hoxb1 reporter (mHoxb1-luc) in which the S3 binding site was mutated (Fig. 6C, bar 3). 
These results further demonstrate that Hoxb3 can repress Hoxb1 transcriptional activity 
through the S3 Hoxb3 binding site. Together with the transgenic mouse mutant analysis 
which shows that in Hoxb3
Tg
 mutants Hoxb1 expression in r4 is specifically suppressed, 
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we conclude that Hoxb3 serves as a direct negative regulator of Hoxb1 expression. 
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Discussion 
Using a Hoxb3
 
gain-of-function mutation approach, we have altered the combinatorial 
Hox code in the developing hindbrain rhombomere 4 of the Hoxb3
Tg
 mutant mice. 
Through cellular and molecular analyses of the hindbrain defects of the Hoxb3
Tg
 mutant, 
we demonstrated that Hoxb3 could function as a direct negative regulator of Hoxb1 gene 
in restricting Hoxb1 expression to r4. As shown by in vivo embryo tissue ChIP assay (Fig. 
6B), Hoxb3 binds to the Hoxb1 gene in the caudal hindbrain, thereby represses Hoxb1 
expression during normal hindbrain development. Therefore, Hoxb3 serves to protect the 
posterior hindbrain from the action of Hoxb1, and ensure rhombomere-specific neuronal 
fate determination and migration during normal hindbrain neurogenesis. 
 
In this study we have analysed three independent transgenic mouse lines Hoxb3
Tg2
, 
Hoxb3
Tg7
 and Hoxb3
Tg8
, with the cellular and molecular studies focusing on the Hoxb3
Tg2
 
line for consistency.  Although the level of Hoxb3 protein expression varies among 
these mouse lines as shown by western blot analysis (Fig. 1C), all three mouse lines 
showed clear loss of Hoxb1 expression in r4 (Supplementary Fig. 1M) and displayed 
similar craniofacial defects (Supple. Fig. 1). The lack of a gene dosage/expression level 
effect suggests that Hoxb3 could be a strong repressor, such that low level of Hoxb3 
expression, as seen in the Hoxb3
Tg7
 line, was sufficient to suppress Hoxb1 expression and 
led to distinctive abnormalities as phenocopy of Hoxb1 null mutant. Indeed, 2 out of 8 
transgenic founders had no observable phenotypes (Table 1), it is possible that in those 
mutant founders the expression of the Hoxb3 transgene was below the threshold to trigger 
any alterations in Hoxb1 expression. Interestingly, the Hoxb2 r4 and BA2 enhancer used 
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in the Hoxb3 transgenic construct contains Hoxb1 binding sites and its enhancer function 
is Hoxb1 dependent (Feretti et al 2000, Maconochie et al, 1997). In the Hoxb3
Tg
 mutant, 
when Hoxb1 was suppressed, Hoxb3 transgene expression could still be maintained 
beyond E9.5 (Fig. 1D). Clearly, other Hoxb1-independent mechanisms were involved in 
maintaining the expression of the transgene at later stages, and one possibility would be 
auto-regulation. In our in vivo ChIP analysis, we showed that Hoxb3 could bind to its 
auto-regulatory site B3ARE in the ectopic expression site of r4 and 2
nd
 BA (Fig. 6B). 
Therefore, in the Hoxb3
Tg
 mutants, ectopic Hoxb3 expression was initially activated at 
around E7.5-E8.0 by Hoxb1; by E8.5 when Hoxb1 expression was suppressed, the 
expression of Hoxb3 could be self-sustained by an auto-regulatory mechanism through 
binding to the B3ARE site. 
 
The role of Hoxb3 and Hoxb1 in hindbrain neurogenesis 
By altering the Hox code in r4 with enforced expression of Hoxb3, indeed the identity of 
r4 in the Hoxb3
Tg
 mutant was changed. Most strikingly we found that the expression of 
Hoxb1 in r4 was completely abolished in the mutants from E8.5. Using hindbrain 
rhombomere-specific markers we showed that in the Hoxb3
Tg
 mutant there was no 
apparent transformation of r4 into odd-numbered rhombomeres such as r3 or r5. 
Although Hoxb3 is normally expressed and upregulated in r5 at E9.5, ectopic expression 
of Hoxb3 was insufficient to impose an r5-like character in r4 of the mutant. Therefore, 
the hindbrain segmentation and the establishment of the r4 territory were not affected in 
the Hoxb3
Tg 
mutant, but the identity of r4 was lost with the loss of Hoxb1 expression.  
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The gross phenotype of the Hoxb3
Tg 
mutants including narrower face, impaired whisker 
movement, facial paralysis, retracted lower lip and abnormal facial motor nerves are 
similar to that displayed in the Hoxb1
-/- 
mutants (Arenkiel et al., 2004; Goddard et al., 
1996; Studer et al., 1996). Our neuronal phenotype analysis also confirms that the 
Hoxb3
Tg
 mutant is a phenocopy of the Hoxb1 null mutants. In r4 of the Hoxb3
Tg/+
 mutant 
hindbrain, the FBMs were not specified, CVA neurons were reduced, ectopic 
serotonergic neurons were induced, the distributions of interneurons and efferent neurons 
were altered. In addition, the ectopic motor neurons in r4 of Hoxb3
Tg
 mutants marked by 
Islet1 and Tbx20 antibodies were clustered into two populations (Fig. 4F,H). One 
population of motor neurons formed a column in the medial-ventral region of r4, whereas 
a separate population of motor neurons was located in the dorsal-lateral region, at a 
position similar to that occupied by the trigeminal motor nucleus in r2 along the 
dorsoventral axis of the rhombomere. While the distribution of the Islet1-positive motor 
neurons in the affected r4 forms the basis for the suggestion that there is a transformation 
of r4 to an r2-like rhombomere, the identities of those two populations of motor neurons 
remain unclear and the regulation of the rhombomere-specific dorsoventral distribution of 
motor neurons deserves further characterization.  
 
It has been previously shown that in r5 of the Hoxa3
-/-
 mutants, somatic motorneurons 
(SMs) are reduced; and in r5 Hoxa3
-/-
:Hoxb3
-/-
 double mutant hindbrains, SMs are 
completely lost and replaced by ectopic V2 interneurons (Gaufo et al., 2003). Therefore, 
it is suggested that in r5, Hoxa3 and Hoxb3 are both required for the determination of the 
fate of SMs at early stages. Hoxa3 gain-of-function study in chick embryos has 
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demonstrated that Hoxa3 is sufficient to induce SMs in r1-r4 (Guidato et al., 2003). We 
examined the neuronal phenotypes of the Hoxb3
Tg
 mutant and could not identify any 
r5-like SMs in r4. Therefore, in mouse embryos, Hoxb3 alone is insufficient specify 
somatic motor neurons in an r4 territory. Also, even when Hoxb3 is over-expressed in r4, 
it is insufficient to confer an r5-like identity in the mutant r4. Taken together, Hoxb3 is 
required to interact with Hoxa3 in order to induce the generation of SMs. Therefore, in 
the Hoxb3
Tg
 mutant, there is a possible r4 to r2 identity switch, but not an r4 to r5 identity 
switch.  
 
Hoxb3 suppresses Hoxb1 in hindbrain patterning 
By both in vitro and in vivo molecular analyses, we showed that Hoxb3 can repress 
Hoxb1 transcriptional activity through a specific Hoxb3 binding site located 3’ to the 
Hoxb1 gene, clearly demonstrating that Hoxb3 serves as a direct negative regulator of 
Hoxb1 expression. The function of Hoxb3 as a negative regulator of Hoxb1 could explain 
the regulation of Hox expression during normal hindbrain patterning. Within the 
functional domain of Hoxb3 in the neural tube, the posterior gene Hoxb3 represses the 
anterior gene Hoxb1, supporting the posterior prevalence model of Hox gene 
cross-regulation. As illustrated in Fig. 7A, during normal development, Hoxb1 is 
expressed at E7.5 in a broad region of the neuroectoderm along the anteroposterior axis, 
while Hoxb3 is expressed at a low level in the posterior neural tube. The expression 
pattern of Hoxb3 then extends anteriorly and is upregulated between E8.5 and E9.5 in the 
hindbrain in r5; coincidentally from E8.5 the posterior expression domain of Hoxb1 is 
down-regulated and later turned off in r5 and posterior hindbrain and established a sharp 
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r4/r5 boundary (data shown in Fig. 3). Therefore, Hoxb3 represses Hoxb1 expression in 
the caudal hindbrain from E8.5 to E10.5 to maintain the spatial colinearity of Hox 
expression during hindbrain patterning, such that Hoxb1 expression is restricted to r4 to 
determine the appropriate neurogenesis process for this rhombomere.  
 
The normal establishment of Hoxb1 expression domain is subjected to a complex 
network of cross- and auto-regulation among different Hox members (Gavalas et al., 
2003; Gavalas et al., 1998; Gavalas et al., 2001; Murphy and Hill, 1991; Rossel and 
Capecchi, 1999; Studer et al., 1998) as well as other transcriptional regulators (Barrow et 
al., 2000; Ferretti et al., 2005; Popperl et al., 1995). As summarized in Fig. 7B,C, during 
early development, retinoic acid signaling is required to activate and initiate Hoxb1 
expression through the retinoic acid response element RARE 3’DR2 (Dupe et al., 1997; 
Huang et al., 2002; Marshall et al., 1994). Hoxb1 expression in r4 is then maintained by 
Hoxb1 as well as Hoxa1 through an auto-regulatory element B1ARE located at the 
5’flanking region of the Hoxb1 gene (Gavalas et al., 1998; Gavalas et al., 2001; Popperl 
et al., 1995; Studer et al., 1998). By E9.5, a second negative regulation is triggered by 
retinoic acid signaling through a separate RARE element 5’DR2 to repress the expression 
of Hoxb1 in r3 and r5 (Marshall et al., 1996; Studer et al., 1994). It has been proposed 
that additional elements are needed as the r3/r5 repressor is insufficient to restrict Hoxb1 
expression in r4 (Fox, 2000). In this study, we identified a Hoxb3 binding site S3 which 
is located at the 3’ flanking region of Hoxb1 gene (Fig. 7B). By a series of in vivo ChIP 
analysis, we have shown that in both P19 cells and in mouse embryos, endogenously 
expressed Hoxb3 was consistently bound to the S3 site of the Hoxb1 gene. Using 
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chromatin extracted from caudal hindbrain and anterior spinal cord tissue of E9.5 
wildtype mouse embryos, we could clearly detect direct binding of Hoxb3 to the S3 site 
of Hoxb1. We have further demonstrated that the S3 site was a functional repressor site; 
upon Hoxb3 binding to the S3 site, Hoxb1 directed gene expression was repressed as 
shown in chick in ovo electroporation experiments. Our results shown here have provided 
the molecular mechanism for the function of Hoxb3 as a direct negative regulator of 
Hoxb1.  
 
The role of Hoxb3 as a negative regulator of Hoxb1 is further supported by 
loss-of-function mutant studies. In Hox3 loss-of-function mutants, Hoxb1 expression was 
de-repressed in r6, with associated activation of r4-like FBMs differentiation and 
migration in r6 (Gaufo et al., 2003). Therefore, while Hoxa3, Hoxb3 and Hoxd3 share 
functional redundancy, there is strong genetic evidence that they are required to suppress 
Hoxb1 expression in r6 to prevent it from adopting a r4-like identity. 
 
In addition to cross-regulation by other Hox genes, other regulations are also in place to 
restrict the expression of Hoxb1 to r4 in the hindbrain. Krox20 is another negative 
regulator, by interacting with PIASxβ it represses Hoxb1 expression in r3 and r5 
(Garcia-Dominguez et al., 2006; Giudicelli et al., 2001). Therefore, Hoxb3, Krox20 and 
retinoic acid signaling are all involved in the suppression of Hoxb1 in the hindbrain to 
restrict Hoxb1 expression to r4. In particular, the suppression of Hoxb1 in r5 and the 
posterior hindbrain by Hoxb3 is initiated from E8.5, hence Hoxb3 acts earlier than the 
RARE 5’DR2 r3/r5 repressor. In conclusion, Hoxb3 is an important negative regulator for 
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both temporal and spatial restriction of Hoxb1 expression in r4 in mouse hindbrain 
patterning. 
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Table 1. The penetrant rate for gross and behavioural abnormalities of Hoxb3
Tg
 
gain-of-function transgenic mutant mice 
 
Phenotype 
 
% of transgenic mutants affected 
 
*Transgenic 
founders 
(n=8) 
 
 
Hoxb3
Tg2
 
offspring 
(n=30) 
 
Hoxb3
Tg7 
offspring 
(n=30) 
 
Hoxb3
Tg8
 
offspring 
(n=30) 
 
Reduced pinna size 
 Bilateral reduction 
 Unilateral reduction 
 No reduction 
 
 
75   
0    
25   
 
 
80   
10   
10   
 
 
10 
0 
90 
 
 
30 
20 
50 
Impaired whisker movement 
 Bilateral impairment 
 Unilateral impairment 
 No impairment 
 
62.5   
0    
37.5   
 
60  
30   
10  
 
30 
10 
60 
 
50 
30 
20 
Facial paralysis 
Head tilting response 
Circling response  
Abnormal reaching response 
Abnormal preyer reflex  
 
62.5   
75   
62.5   
75   
75   
90    
100   
100   
100   
100   
40 
100 
100 
100 
100 
80 
100 
100 
100 
100 
          
        *The 8 independent transgenic founders Hoxb3-Tg1 to -Tg8  
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Figure Legends 
Figure 1. Generation of Hoxb3
Tg
 mutant mice. (A) Diagram showing transgenic DNA 
construct with Hoxb2 r4 enhancer and Hoxb3 coding region. Triangle: Prep/Meis binding 
site; oval: Hoxb1/Pbx binding site; arrowheads: positions of primers for PCR genotyping 
Hoxb3
Tg
 mutants which generate a 450 bp band as shown. (B) Southern blot analysis of 
SacI cut genomic DNA from Hoxb3-Tg2, Tg7 and Tg8 mouse lines using BglII-EcoRI 
Hoxb2 fragment as probe. The 11.5 kb band is the endogenous Hoxb2 genomic fragment 
(WT); 5 kb band is from tandem repeats of the Hoxb3 transgenic construct (Tg); other 
bands are derived from transgene integration sites. (C) Western blot analysis of Hoxb3 
protein expression in the ectopic sites r4/2
nd
 BA in E10.5 wildtype, Hoxb3
Tg2/+
, 
Hoxb3
Tg7/+
 and Hoxb3
Tg8/+ 
transgenic embryos. (D) Whole-mount in situ hybridization 
analysis of Hoxb3 expression in WT and Hoxb3
Tg/+ 
embryos at E9.0-E10.5. Arrowheads 
in Hoxb3
Tg/+
 mark the ectopic sites of Hoxb3 expression; numbers indicate branchial 
arch.  
 
Figure 2. Craniofacial abnormalities in Hoxb3
Tg2/+
 mutants. Hoxb3
Tg2/+
 mutant mice have 
a narrower face (E), receded lower lip (F) and abnormal reaching response (G) compared 
with wildtype (A-C). Examination of the facial nerve at adult stage showed the absence 
of the mandibular branch of the facial nerve in Hoxb3
Tg2/+ 
mutants (H, asterisk). zb, 
zygomatic branch; bb, buccal branch; mb, mandibular branch.  
 
Figure 3. Hoxb1 expression is abolished in r4 of Hoxb3
Tg/+
 embryos. Wildtype and  
Hoxb3
Tg/+
 mutant embryos (E7.5-10.5) were examined by whole-mount in situ 
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hybridization using Hoxb3 (A-H), Hoxb1 (I-L, N-Q), Hoxb2 (M,R), Wnt8a (S,U), Kr 
(T,V), Krox20 (W,Y) and EphA4 (X,Z) riboprobes. Arrowheads indicate r5 (F) and r4 (J); 
asterisks indicate ectopic r4. 
 
Figure 4. Abnormal neurogenesis in r4 of Hoxb3
Tg/+
 mutant E11.5 embryos. (A-J) 
Flat-mounted embryos analysed by whole-mount in situ hybridization using Islet1 (A,F), 
Phox2b (B,G), Tbx20 (C,H), Gata3 (D,I) and Gata2 (E,J) riboprobes. Neuronal tract 
tracing of FBM (K, M) and CVA (L,N) neurons in wildtype and Hoxb3
Tg/+ 
mutant 
hindbrains. Immunostaining of neuronal subtypes using Islet1 (O,P), 5-HT (Q,R) and 
Lim3 (S,T) antibodies on transverse sections through r2, r4 and r6 of wildtype and 
Hoxb3
Tg/+ 
mutant hindbrains. The abnormal generation of ectopic 5-HT
+ 
serotonergic 
neurons (Blue), reduced Islet1
+ 
motor neurons (Green) associated with the ventral shift of 
Lim3
+
 (Red) interneurons are summarized in the schematic diagram. Asterisks indicate 
abnormal neurogenesis in r4. SN, serotonergic neurons; MN, motor nucleus; V2, 
interneurons.  
 
Figure 5. Identification of Hoxb3 binding sites in the Hoxb1 gene locus. (A) Alignment 
of Hoxb1 5’ and 3’ flanking region sequences from mouse, rat, human, orangutan, dog 
and cow. Three potential Hoxb3 binding sites S1-S3 were found in the conserved region. 
(B) Comparison of the sequences of the S1, S2 and S3 binding sites and the Hoxb3 
consensus binding site, with the core sequence underlined. (C) Electrophoretic Mobility 
Shift Assay of Hoxb3 protein and the S3 site on Hoxb1. Hoxb3-GST fusion protein can 
bind to oligonucleotide containing wildtype S3 sequence. The amount of protein, 
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wildtype and mutant oligonucleotides used are as indicated, the sequences of the mutant 
oligonucleotides (S3-M1, M2, M12) are as shown. 
 
Figure 6. Hoxb3 protein can bind to the S3 site on Hoxb1 and suppress Hoxb1 gene 
expression in vivo. (A) Chromatin immunoprecipitation (ChIP) analysis using RA-treated 
P19 cell nuclear extracts. Primers were designed to amplify chromatin fragments which 
contain S1, B1ARE/S2, S3 and B3ARE sites. Hoxb3 could bind to the S3 site on Hoxb1, 
but not S1 nor S2 sites. As positive control we showed that Hoxb3 can bind to the 
B3ARE site on the Hoxb3 gene; as negative control we showed that neither Hoxb1 nor 
Hoxb4 can bind to the S3 site, though Hoxb1 can bind to the B1ARE site. (B) In vivo 
ChIP analysis using chromatin extracts from forebrain (1), r4/2
nd
 BA (2), caudal 
hindbrain/spinal cord (3) of E9.5 wildtype, Hoxb3
Tg
 and Hoxb3
-/- 
null mutant embryos. In 
wildtype embryos, Hoxb3 protein could bind to the S3 and B3ARE sites in the caudal 
hindbrain/spinal cord (3). In Hoxb3
Tg/+
 mutant embryos. Hoxb3 could bind to the S3 and 
B3ARE sites in extracts of r4/2
nd
 BA (2) and caudal hindbrain/spinal cord (3). No 
binding could be detected in extracts from Hoxb3
-/-
 mutant embryos. (C) Chick in ovo 
luciferase activity assay with Hoxb3 expression vector and Hoxb1 luciferase reporter. 
Co-electroporation of Hoxb3 expression vector and wildtype Hoxb1-luc showed that 
Hoxb3 expression repressed Hoxb1 transcriptional activity. The transcriptional repression 
activity of Hoxb3 is S3 site dependent. Bracket indicates statistical significant difference, 
n=10.  
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Figure 7. Hoxb3 is a negative regulator for restricting Hoxb1 expression domain to r4 in 
the hindbrain. (A) The complementary expression domains of Hoxb1 (green) and Hoxb3 
(purple) from E7.5 to 10.5 are dynamically regulated. By genetics and molecular analyses 
we have shown that Hoxb3 can repress Hoxb1 expression and contribute to the restriction 
of Hoxb1 expression to r4. (B) Positive and negative regulatory sites for establishment 
and maintenance of Hoxb1 expression in r4. RARE 3’DR2 and B1ARE sites mediate 
initiation and maintenance of Hoxb1 expression in r4. RARE 5’DR2 mediates 
suppression of Hoxb1 expression in r3/r5. Hoxb3 S3 binding site is required for 
suppression of Hoxb1 in caudal hindbrain and spinal cord to restrict Hoxb1 expression 
domain in the posterior. (C) Cross-regulatory network of Hox1, 2 and 3 genes in 
hindbrain r4, r5 to the posterior hindbrain during initiation and maintenance of 
rhombomeric boundary of Hoxb1 expression.  
 
Supplementary Figure 1. (A) Craniofacial dysmorphogenesis in the Hoxb3 transgenic 
mouse lines Hoxb3-Tg2 (D-F), Tg7 (G-I) and Tg8 (J-L). (A-K) Craniofacial defects in 
mutant mice. The Hoxb3
Tg/+
 mutant mice had narrower face (D,G,J), facial paralysis, 
impaired whisker movement (E,H,K) and absence of the mandibular branch of the VII 
nerve (asterisks in F,I,L). bb, buccal branch; mb, mandibular branch; zb, zygomatic 
branch. (M) Hoxb1 expression is abolished in r4 of Hoxb3
Tg2/+
, Hoxb3
Tg7/+
 and 
Hoxb3
Tg8/+
 embryos at E10.5 by whole mount in situ hybridization using Hoxb1 
riboprobe. 
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Supplementary Figure 2. Analysis of expression of Hoxb2 (A-D) and Hoxa2 (E-H) in 
E9.5 wild-type (A,B,E,F) and Hoxb3
Tg
 (C,D,G,H) embryos by wholemount in situ 
hybridization. In wild-type embryos, Hoxb2 (A,B) was expressed from r3 to the posterior 
neural tube and Hoxa2 (E,F) expressed from r2 to the posterior neural tube at E9.5. In 
Hoxb3
Tg 
embryos, expression of Hoxb2 (A,B) was reduced in r4, but expression of Hoxa2 
was not affected (G,H). 
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Table 1. The penetrant rate for gross and behavioural abnormalities of Hoxb3
Tg
 
gain-of-function transgenic mutant mice 
 
Phenotype 
 
% of transgenic mutants affected 
 
*Transgenic 
founders 
(n=8) 
 
 
Hoxb3
Tg2
 
offspring 
(n=30) 
 
Hoxb3
Tg7 
offspring 
(n=30) 
 
Hoxb3
Tg8
 
offspring 
(n=30) 
 
Reduced pinna size 
 Bilateral reduction 
 Unilateral reduction 
 No reduction 
 
 
75   
0    
25   
 
 
80   
10   
10   
 
 
10 
0 
90 
 
 
30 
20 
50 
Impaired whisker movement 
 Bilateral impairment 
 Unilateral impairment 
 No impairment 
 
62.5   
0    
37.5   
 
60  
30   
10  
 
30 
10 
60 
 
50 
30 
20 
Facial paralysis 
Head tilting response 
Circling response  
Abnormal reaching response 
Abnormal preyer reflex  
 
62.5   
75   
62.5   
75   
75   
90    
100   
100   
100   
100   
40 
100 
100 
100 
100 
80 
100 
100 
100 
100 
          
        *The 8 independent transgenic founders Hoxb3-Tg1 to -Tg8  
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